Higher Rates of Persistence and Adherence in Patients with Type 2 Diabetes Initiating Once-Weekly vs Daily Injectable Glucagon-Like Peptide-1 Receptor Agonists in US Clinical Practice (STAY Study).

WH, Polonsky; R, Arora; M, Faurby; J, Fernandes; A, Liebl

doi:10.1007/s13300-021-01189-6

Public

Higher Rates of Persistence and Adherence in Patients with Type 2 Diabetes Initiating Once-Weekly vs Daily Injectable Glucagon-Like Peptide-1 Receptor Agonists in US Clinical Practice (STAY Study).

Shared by NobleBlocks on Dec 16, 2021 • 12:00 AM UTC

Authors:

Polonsky WH

Arora R

Faurby M

Abstract

<h4>Introduction</h4>Reducing dosing frequency may lower treatment burden and improve persistence and adherence. This retrospective, observational study assessed persistence and adherence in patients with type 2 diabetes (T2D) initiating once-weekly or daily injectable glucagon-like peptide-1 recept...

Subject

Adherence

Persistence

Type 2 diabetes

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!